相关临床试验
0
0 进行中
药物批准
3
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
- Alpha Modus Holdings filed a patent infringement lawsuit against Indian software company Allerin Tech Pvt. Ltd., alleging infringement of ten patents covering AI-driven retail technologies. - The lawsuit targets Allerin's "AllView" AI platform, which provides machine vision, object detection, and retail applications that Alpha Modus claims practice its patented methods. - This legal action is part of Alpha Modus's broader enforcement strategy against major retailers and tech companies in the $60+ billion retail media and self-service kiosk markets. - CEO William Alessi stated that most companies practicing AI in retail will struggle not to infringe on Alpha Modus's patents, describing the company's IP portfolio as a "minefield" for competitors.
- Mark Cuban's Cost Plus Drugs company has partnered with Giant Eagle, a supermarket chain with over 200 stores across five states, to expand access to discounted prescription medications. - The partnership allows Cost Plus Drugs program participants to pick up qualifying prescriptions at Giant Eagle pharmacy locations using Team Cuban pharmacy benefit cards. - Cost Plus Drugs aims to reduce medication costs by sourcing directly from manufacturers and eliminating pharmacy benefit managers, while operating its own manufacturing facility in Dallas. - The collaboration comes as Giant Eagle acquired prescription lists from 78 Rite Aid stores during the pharmacy chain's bankruptcy proceedings.
- Retail pharmacies like Walgreens, Walmart, and Kroger are expanding into clinical trial recruitment, leveraging their reach to improve patient enrollment and diversity in studies. - Decentralized clinical trials, spurred by the COVID-19 pandemic and FDA support, are driving this trend, with pharmacies acting as intermediaries between drug companies and patients. - These pharmacies aim to address the issue of low clinical trial enrollment, as nearly 80% of trials fail to meet initial targets, costing drug developers millions in potential revenue. - While CVS Health is phasing out its clinical trial unit, other major pharmacies are investing in this area, potentially impacting revenue for traditional clinical laboratories and pathology groups.
